Lee ES - Search Results

1

Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.

O'Regan RM, Osipo C, Ariazi E, Lee ES, Meeke K, Morris C, Bertucci A, Sarker MA, Grigg R, Jordan VC. O'Regan RM, et al. Among authors: lee es. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2255-63. doi: 10.1158/1078-0432.CCR-05-2584. Clin Cancer Res. 2006. PMID: 16609042

2

Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.

Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC. Yao K, et al. Among authors: lee es. Clin Cancer Res. 2000 May;6(5):2028-36. Clin Cancer Res. 2000. PMID: 10815929

3

Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.

Schafer JM, Lee ES, O'Regan RM, Yao K, Jordan VC. Schafer JM, et al. Among authors: lee es. Clin Cancer Res. 2000 Nov;6(11):4373-80. Clin Cancer Res. 2000. PMID: 11106256

4

Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.

Lee ES, Schafer JM, Yao K, England G, O'Regan RM, De Los Reyes A, Jordan VC. Lee ES, et al. Clin Cancer Res. 2000 Dec;6(12):4893-9. Clin Cancer Res. 2000. PMID: 11156249

5

Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts.

Schafer JM, Lee ES, Dardes RC, Bentrem D, O'Regan RM, De Los Reyes A, Jordan VC. Schafer JM, et al. Among authors: lee es. Clin Cancer Res. 2001 Aug;7(8):2505-12. Clin Cancer Res. 2001. PMID: 11489833

6

Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance.

Balaburski GM, Dardes RC, Johnson M, Haddad B, Zhu F, Ross EA, Sengupta S, Klein-Szanto A, Liu H, Lee ES, Kim H, Jordan VC. Balaburski GM, et al. Among authors: lee es. Int J Oncol. 2010 Aug;37(2):387-98. doi: 10.3892/ijo_00000687. Int J Oncol. 2010. PMID: 20596666 Free PMC article.

7

In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.

Takei H, Lee ES, Jordan VC. Takei H, et al. Among authors: lee es. Breast Cancer. 2002;9(1):39-42. doi: 10.1007/BF02967545. Breast Cancer. 2002. PMID: 12196720

8

Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.

Liu H, Lee ES, Gajdos C, Pearce ST, Chen B, Osipo C, Loweth J, McKian K, De Los Reyes A, Wing L, Jordan VC. Liu H, et al. Among authors: lee es. J Natl Cancer Inst. 2003 Nov 5;95(21):1586-97. doi: 10.1093/jnci/djg080. J Natl Cancer Inst. 2003. PMID: 14600091

9

Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.

Takei H, Lee ES, Cisneros A, Jordan VC. Takei H, et al. Among authors: lee es. Cancer Lett. 2000 Jul 31;155(2):129-35. doi: 10.1016/s0304-3835(00)00418-3. Cancer Lett. 2000. PMID: 10822127

10

Silencing and reactivation of the selective estrogen receptor modulator-estrogen receptor alpha complex.

Liu H, Lee ES, Deb Los Reyes A, Zapf JW, Jordan VC. Liu H, et al. Among authors: lee es. Cancer Res. 2001 May 1;61(9):3632-9. Cancer Res. 2001. PMID: 11325832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,706 results

Search Page

Filters